Regencell Bioscience Holdings reported total assets of $0.00B and total liabilities of $0.00B for the quarter ended Dec 2025. This balance sheet covers 7 quarters of results from Jun 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2020 | Jun2021 | Jun2022 | Jun2023 | Jun2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Current Assets | |||||||
| Cash & EquivalentsCash & Equiv. | 0.00B | 0.00B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B |
| Short-term InvestmentsInvestments (Current) | 0.01B | -0.01B | 0.01B | 0.00B | |||
| Cash & Current Investments | 0.00B | 0.00B | 0.02B | -0.01B | 0.01B | 0.00B | 0.00B |
| Prepaid Assets | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||
| Current Assets | 0.00B | 0.01B | 0.00B | 0.00B | |||
| Non-Current Assets | |||||||
| Property, Plant & Equipment (Net) | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Other Non-Current Assets | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Non-Current Assets | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Assets | 0.00B | 0.01B | 0.01B | 0.00B | |||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Notes Payables | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 106.00 | |
| Payables | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 106.00 | |
| Accumulated Expenses | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Other Accumulated Expenses | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |
| Short term Debt | 3,069.91B | 0.00B | |||||
| Total Current Liabilities | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Non-Current Liabilities | |||||||
| Convertible Debt | 0.00B | ||||||
| Minority Interest | 0.00B | -0.00B | |||||
| Operating Leases | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||
| Total Liabilities | 0.00B | 0.00B | 0.00B | 0.00B | |||
| Shareholder's Equity | |||||||
| Total Debt | 3,069.91B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 106.00 |
| Common Equity | -0.00B | -0.00B | 0.02B | 0.01B | 0.01B | 0.00B | 0.00B |
| Liabilities and Shareholders Equity | 0.00B | 0.01B | 0.01B | 0.00B | |||
| Retained Earnings | -0.00B | -0.00B | -0.01B | -0.02B | -0.02B | -0.03B | -0.03B |
| Preferred Shares | 100.00 | 130.00 | 130.00 | 0.00B |
Pull Regencell Bioscience Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=RGC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "RGC", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=RGC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();